DAM
TTPH

DLD Asset Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

DLD Asset Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,500
Closed -$1.64M – 117
2017
Q2 		$1.64M Buy
+11,500
New +$1.78M 0.21% 39

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DLD Asset Management's TTPH Position: Q3 2017 in Review

DLD Asset Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2017, closing a stake of 11,500 shares — an estimated $1.64M sold.

DLD Asset Management first reported a position in TTPH in Q2 2017 and held it in 1 quarter. The position peaked at $1.64M in Q2 2017. 94 funds tracked by Wall St. Rank hold TTPH as of Q3 2017.

  • DLD Asset Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • DLD Asset Management sold 11,500 Tetraphase Pharmaceuticals, Inc. shares in Q3 2017, an estimated $1.64M.
  • DLD Asset Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2017 and held it in 1 quarter.
  • DLD Asset Management's Tetraphase Pharmaceuticals, Inc. position peaked at $1.64M in Q2 2017.
  • 94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2017.

Based on DLD Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.